Aims & Scope
Current Cancer Therapy Reviews publishes full-length review/mini-reviews, original research articles, drug clinical trial studies and guest-edited thematic issues on all the latest advances in clinical oncology, cancer therapy and pharmacology. The journal aims to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in the field of cancer therapy. It covers papers related to prevention, diagnosis and treatment of all types of cancers through biomarkers testing, biopsy, chemotherapy, hormone therapy, gene therapy, hyperthermia, immunotherapy, irreversible electroporation, laser therapy, photodynamic therapy, radiation therapy, radiotherapy and stem cell transplantation.
Cambridge Scientific Abstracts (CSA)/ProQuest, Chemical Abstracts Service/SciFinder, ChemWeb, CNKI Scholar, Dimensions, EBSCO, EMBASE, Emerging Sources Citation Index (ESCI) by Clarivate Analytics, EMNursing, ERA 2018, Genamics JournalSeek, Google Scholar, Index Copernicus, J-Gate, JournalTOCs, Open Abstracts (I4OA), MediaFinder®-Standard Periodical Directory, PubsHub, QOAM, Scilit, Scopus, Suweco CZ, TOC Premier, and Ulrich's Periodicals Directory.
Quick processing and publication of the submitted papers. The manuscript will be published online within 20 days of final acceptance.
30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is
Multiple issue copies at discounted rates.
"Our team has found the articles in current cancer therapy reviews to be very insightful and an
accurate representation of the present state-of-the-art for academic and practicing radiation
Charles R. Thomas
Univ. of Texas Health Science Center, USA
(School of Biosciences and Technology, VIT University, Vellore, Tamil Nadu, India.)